经颅直流电刺激与假刺激治疗成人注意缺陷多动障碍注意力不集中的随机临床试验
第4周活性组CASRS-I注意力不集中评分18.88(5.79)低于假刺激组23.63(3.97),治疗×时间交互β=-3.18(95%CI -4.60至-1.75;P<.001),活性组轻度不良事件更常见。
要点
- 4周家庭tDCS较假刺激显著降低成人ADHD注意力不集中评分(交互β=-3.18,P<.001)
- 第4周CASRS-I评分活性组18.88(5.79)vs假刺激组23.63(3.97)
- 活性组轻度不良事件更常见,包括皮肤发红、头痛和头皮灼伤
核心结论
- 每日使用家庭tDCS设备4周可改善未服兴奋剂成人ADHD患者的注意力,家庭tDCS可能成为非药物替代选择。
研究设计与样本
- 随机、双盲、平行、假对照临床试验(TUNED),2019年7月至2021年7月在单中心门诊学术机构开展。
主要发现
- 第4周CASRS-I注意力不集中评分活性tDCS组为18.88(5.79),假tDCS组为23.63(3.97)。
- 线性混合效应模型显示CASRS-I治疗×时间交互有统计学意义(βinteraction=-3.18;95%CI -4.60至-1.75;P<.001),活性tDCS组在3次评估中注意力不集中症状较假tDCS组下降。
- 活性tDCS组轻度不良事件更频繁,尤其是皮肤发红、头痛和头皮灼伤。
关键数值与推荐
- 主要结局为临床医师版成人ADHD自评量表1.1版(CASRS-I)注意力不集中评分。
- 排除标准包括当前兴奋剂药物治疗、当前中度至重度抑郁或焦虑症状、过去一年内有躁狂或抑郁发作的双相障碍诊断、精神分裂症或其他精神病性障碍诊断、孤独症谱系障碍诊断。
临床怎么用
- 对于未服兴奋剂的成人ADHD患者,每日家庭tDCS持续4周可能改善注意力不集中症状。
- 活性tDCS组轻度不良事件更常见,包括皮肤发红、头痛和头皮灼伤。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Transcranial direct current stimulation (tDCS) may improve symptoms of inattention in adults with attention-deficit/hyperactivity disorder (ADHD). However, previous trials are characterized by small sample sizes, heterogeneous methodologies, and short treatment periods using clinic-based tDCS. OBJECTIVE: To determine the efficacy and safety of home-based tDCS in treating inattention symptoms in adult patients with ADHD. DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind, parallel, sham-controlled clinical trial (tDCS for the Treatment of Inattention Symptoms in Adult Patients With ADHD [TUNED]), conducted from July 2019 through July 2021 in a single-center outpatient academic setting. Of 277 potential participants screened by phone, 150 were assessed for eligibility on site, and 64 were included. Participants were adults with ADHD, inattentive or combined subtype. Exclusion criteria included current stimulant drug treatment, current moderate to severe symptoms of depression or anxiety, diagnosis of bipolar disorder with a manic or depressive episode in the last year, diagnosis of schizophrenia or another psychotic disorder, and diagnosis of autism spectrum disorder; 55 of participants completed follow-up after 4 weeks. INTERVENTIONS: Thirty-minute daily sessions of home-based tDCS for 4 weeks, 2 mA anodal-right and cathodal-left prefrontal stimulation with 35-cm2 carbon electrodes. MAIN OUTCOMES AND MEASURES: Inattentive scores in the clinician-administered version of the Adult ADHD Self-report Scale version 1.1 (CASRS-I). RESULTS: Included in this trial were 64 participants with ADHD (31 [48%] inattentive presentation and 33 [52%] combined presentation), with a mean (SD) age of 38.3 (9.6) years. Thirty participants (47%) were women and 34 (53%) were men. Fifty-five finished the trial. At week 4, the mean (SD) inattention score, as measured with CASRS-I, was 18.88 (5.79) in the active tDCS group and 23.63 (3.97) in the sham tDCS group. Linear mixed-effects models revealed a statistically significant treatment by time interaction for CASRS-I (βinteraction = -3.18; 95% CI, -4.60 to -1.75; P < .001), showing decreased symptoms of inattention in the active tDCS group over the 3 assessments compared to the sham tDCS group. Mild adverse events were more frequent in the active tDCS group, particularly skin redness, headache, and scalp burn. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, daily treatment with a home-based tDCS device over 4 weeks improved attention in adult patients with ADHD who were not taking stimulant medication. Home-based tDCS could be a nonpharmacological alternative for patients with ADHD. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04003740.
引用
- Leffa DT, Grevet EH, Bau CHD, et al. Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder: The TUNED Randomized Clinical Trial. JAMA Psychiatry. 2022. PMID: 35921102. doi:10.1001/jamapsychiatry.2022.2055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。